• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Safety

  • Print
  • Share
  • E-mail

Tenex (guanfacine hydrochloride) Tablets

Detailed View: Safety Labeling Changes Approved By FDA Center for Drug Evaluation and Research (CDER)

 

July 2013

Summary View

PRECAUTIONS

Pediatric Use
  • Hallucinations have been reported in pediatric patients receiving Tenex for treatment of attention-deficit hyperactivity disorder